Abstract
RJ 2.2.5 is a human B cell mutant, derived from Raji cells, which has lost expression of major histocompatibility complex (MHC) class II genes because of a defect in the AIR1 locus function. The MHC class II-positive phenotype can be restored by introducing an active AIR1 locus or its mouse equivalent, Air-1. An example of the latter is the H4 cell hybrid, derived by somatic cell fusion between RJ 2.2.5 and mouse class II-positive spleen cells. H4 contains a single mouse chromosome, autosome 16, in which the Air-1 locus maps, and an entire RJ 2.2.5-derived genome. In the present study we show that the physiologic target of the Air-1 locus product is contained within a limited HLA-DRA promoter sequence of 300 base pairs, encompassing the crucial Y, X, and W cis-acting elements. A plasmid construct, pDRA300neo, containing the HLA-DRA promoter sequence which drives the expression of the neomycin resistance gene, has been stably integrated in the genome of the H4 hybrid. Transfectants selected in the presence of G418 retain mouse chromosome 16 and express the DR genes. On the other hand, transfectants grown in a non-selective medium segregate mouse chromosome 16; this is accompanied by a loss of DRA gene expression and G418 resistance, although pDRA300neo is still integrated in the genome. These results offer scope for using this experimental model to clone the Air-1 gene in a straightforward way.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Accolla, R. S. Human B cell variants immunoselected against a single Ia subset have lost expression of several Ia antigen subsets. J Exp Med 157: 1053–1058, 1983
Accolla, R. S., Carra, G., and Guardiola, J. Reactivation by a trans-acting factor of human major histocompatibility complex Ia gene expression in interspecies hybrids between an Ia-negative human B-cell variant and an Ia-positive mouse B-cell lymphoma. Proc Natl Acad Sci USA 82: 5145–5149, 1985 a
Accolla, R. S., Scarpellino, L., Carra, G., and Guardiola, J. Trans-acting element(s) operating across species barriers positively regulate the expression of major histocompatibility complex class II genes. J Exp Med 162: 1117–1133, 1985 b
Accolla, R. S., Jotterand-Bellomo, M., Scarpellino, L., Maffei, A., Carra, G., and Guardiola, J. aIr-1, a newly found locus on mouse chromosome 16 encoding a trans-acting activator factor for MHC class II gene expression. J Exp Med 164: 369–374, 1986
Accolla, R. S., Auffray, C., Singer, D. S., and Guardiola, J. The molecular biology of MHC genes. Immunol Today 12: 97–100, 1991
Basta, P., Sherman, P. A., and Ting, J. P. Y. Identification of an interferon-γ response region 5′ of the human histocompatibility leukocyte antigen DR alpha chain gene which is active in human glioblastoma multiforme lines. J Immunol 138: 1275–1280, 1987
Benichou, B. and Strominger, J. L. Class II antigen negative patient and mutant B cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. Proc Natl Acad Sci USA 88: 4285–4288, 1991
Benoist, C. and Mathos, D. Regulation of major histocompatibility complex class II genes: X, Y and other letters of the alphabet. Annu Rev Immunol. 8: 681–715, 1990
Bull, M., van Hoef, A., and Gorski, J. Transcription analysis of class II human leukocyte antigen genes from normal and immunodeficient B lymphocytes, using polymerase chain reaction. Mol Cell Biol 10: 3792–3796, 1990
Calman, A. F. and Peterlin, B. M. Mutant human B cell lines deficient in class II major histocompatibility complex transcription. J Immunol 139: 2489–2495, 1987
Dellabona, P., Latron, F., Maffei, A., Scarpellino, L., and Accolla, R. S. Transcriptional control of MHC class II gene expression during differentiation from B cells to plasma cells. J Immunol 142: 2902–2910, 1989
Gladstone, P. and Pious, D. Stable variants affecting B cell alloantigens in human lymphoid cells. Nature 271: 459–461, 1978
Glimcher, L. H. and Kara, C. J. Sequences and factors: a guide to MHC class-II transcription. Annu Rev Immunol 10: 13–49, 1992
Guillemot, F., Auffray, C., Orr, H. T., and Strominger, J. L. MHC antigen genes. In B. D. Hames and D. M. Glover (eds.): Molecular Immunology, pp. 81–143, IRL Press, Oxford, 1988
Hume, C. R. and Lee, J. S. Congenital immunodeficiencies associated with absence of HLA class II antigens on lymphocytes result from distinct mutations in trans-acting factors. Hum Immunol 26: 288–309, 1989
Kara, C. J. and Glimcher, L. H. In vivo footprinting of MHC class II genes: bare promoters in the bare lymphocyte syndrome. Science 252: 709–712, 1991
Koch, W., Candeias, S., Guardiola, J., Accolla, R. S., Benoist, C., and Mathis, D. An enhancer factor defect in a mutant Burkitt lymphoma cell line. J Exp Med 167: 1781–1790, 1988
Latron, F., Jotterand-Bellomo, M., Maffei, A., Scarpellino, L., Bernard, M., Strominger, J. L., and Accolla, R. S. Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. Proc Natl Acad Sci USA 85: 2229–2233, 1988
Lisowska Grospierre, B., Charron, D. B., de Preval, C., Durandy, A., and Griscelli, C. A defect in the regulation of major histocompatibility complex class II gene expression in human HLA-DR negative lymphocytes from patients with combined immunodeficiency syndrome. J Clin Invest 76: 381–385, 1985
Maffei, A., Scarpellino, L., Bernard, M., Carra, G., Jotterand-Bellomo, M., Guardiola, J., and Accolla, R. S. Distinct mechanims regulate class II gene expression in B cells and macrophages. J Immunol 139: 942–948, 1987
Maniatis, T., Fritsch, E. F., and Sambrook, J. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, 1982
Mannhalter, J. W., Wolf, H., DeCunha, M., Gadner, H., and Eibl, M. Induction of an alloresponse by lymphocytes from a patient with MHC class II deficiency. FASEB J (Abstr 3, A1274): 1990
Sartoris, S., Scupoli, M. T., Scarpellino, L., Paiola, F., Jotterand-Bellomo, M., Tridente, G., and Accolla, R. S. Inducible and constitutive MHC class II gene expression. Distinct tissue-specific genetic controls. J Immunol 145: 1960–1967, 1990
Seidl, C., Saraiya, C., Osterweil, Z., Ping Fu, Y., and Lee, J. S. Genetic complexity of regulatory mutants defective for HLA class II gene expression. J Immunol 148: 1576–1584, 1992
Sherman, P. A., Basta, P. V., and Ting, J. P. Y. Upstream DNA sequences required for tissue-specific expression of HLA-DR alpha gene. Proc Natl Acad Sci USA 84: 4254–4258, 1987
Sloan, J. H., and Boss, J. M. Conserved upstream sequences of human class II major histocompatibility genes enhance expression of class II genes in wild-type but not mutant B-cell lines. Proc Natl Acad Sci USA 85: 8186–8190, 1988
Southern, P. J. and Berg, P. Transformation of mammalian cells to antibiotic resistance with a bacterial gene under control of the SV40 early region promoter. J Molec Appl Genet 1: 327–341, 1982
Tsang, S. Y., Nakanishi, M., and Peterlin, B. M. B-cell-specific and interferon-γ-inducible regulation of the HLA-DR alpha gene. Proc Natl Acad Sci USA 85: 8598–8602, 1988
Author information
Authors and Affiliations
Additional information
Correspondence to: R. S. Accolla.
Rights and permissions
About this article
Cite this article
Sartoris, S., De Lerma Barbaro, A., Cestari, T. et al. Physiologic target of the Air-1 trans-activator revealed by stable transfection assay. Immunogenetics 39, 8–14 (1994). https://doi.org/10.1007/BF00171791
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF00171791